Prognostic value of histopathology and trends in cervical cancer: A SEER population study

Vincent Vinh-Hung, Claire Bourgain, Georges Vlastos, G. Cserni, Mark De Ridder, Guy Storme, Anne Thérèse Vlastos

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Background: Histopathology is a cornerstone in the diagnosis of cervical cancer but the prognostic value is controversial. Methods: Women under active follow-up for histologically confirmed primary invasive cervical cancer were selected from the United States Surveillance, Epidemiology, and End Results (SEER) 9-registries public use data 1973-2002. Only histologies with at least 100 cases were retained. Registry area, age, marital status, race, year of diagnosis, tumor histology, grade, stage, tumor size, number of positive nodes, number of examined nodes, odds of nodal involvement, extent of surgery, and radiotherapy were evaluated in Cox models by stepwise selection using the Akaike Information Criteria. Results: There were 30,989 records evaluable. From 1973 to 2002, number of cases dropped from 1,100 new cases/year to 900/year, but adenocarcinomas and adenosquamous carcinoma increased from 100/year to 235/year. Median age was 48 years. Statistically significant variables for both overall and cause-specific mortality were: age, year of diagnosis, race, stage, histology, grade, hysterectomy, radiotherapy, tumor size and nodal ratio. The histological types were jointly significant, P <0.001. Cause-specific mortality hazard ratios by histological type relatively to non-microinvasive squamous cell carcinoma were: microinvasive squamous cell carcinoma 0.28 (95% confidence interval: 0.20-0.39), carcinoma not otherwise specified 0.91 (0.79-1.04), non-mucinous adenocarcinoma 1.06 (0.98-1.15), adenosquamous carcinoma 1.35 (1.20-1.51), mucinous adenocarcinoma 1.52 (1.23-1.88), small cell carcinoma 1.94 (1.58-2.39). Conclusion: Small cell carcinoma and adenocarcinomas were associated with poorer survival. The incidental observation of increasing numbers of adenocarcinomas despite a general decline suggests the inefficiency of conventional screening for these tumors. Increased incidence of adenocarcinomas, their adverse prognosis, and the young age at diagnosis indicate the need to identify women who are at risk.

Original languageEnglish
Article number164
JournalBMC Cancer
Volume7
DOIs
Publication statusPublished - Aug 23 2007

Fingerprint

Uterine Cervical Neoplasms
Epidemiology
Adenocarcinoma
Adenosquamous Carcinoma
Histology
Small Cell Carcinoma
Population
Registries
Squamous Cell Carcinoma
Neoplasms
Radiotherapy
Mucinous Adenocarcinoma
Mortality
Marital Status
Hysterectomy
Proportional Hazards Models
Observation
Confidence Intervals
Carcinoma
Survival

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Vinh-Hung, V., Bourgain, C., Vlastos, G., Cserni, G., De Ridder, M., Storme, G., & Vlastos, A. T. (2007). Prognostic value of histopathology and trends in cervical cancer: A SEER population study. BMC Cancer, 7, [164]. https://doi.org/10.1186/1471-2407-7-164

Prognostic value of histopathology and trends in cervical cancer : A SEER population study. / Vinh-Hung, Vincent; Bourgain, Claire; Vlastos, Georges; Cserni, G.; De Ridder, Mark; Storme, Guy; Vlastos, Anne Thérèse.

In: BMC Cancer, Vol. 7, 164, 23.08.2007.

Research output: Contribution to journalArticle

Vinh-Hung, V, Bourgain, C, Vlastos, G, Cserni, G, De Ridder, M, Storme, G & Vlastos, AT 2007, 'Prognostic value of histopathology and trends in cervical cancer: A SEER population study', BMC Cancer, vol. 7, 164. https://doi.org/10.1186/1471-2407-7-164
Vinh-Hung, Vincent ; Bourgain, Claire ; Vlastos, Georges ; Cserni, G. ; De Ridder, Mark ; Storme, Guy ; Vlastos, Anne Thérèse. / Prognostic value of histopathology and trends in cervical cancer : A SEER population study. In: BMC Cancer. 2007 ; Vol. 7.
@article{72147d89d631467cbe21a21263eea402,
title = "Prognostic value of histopathology and trends in cervical cancer: A SEER population study",
abstract = "Background: Histopathology is a cornerstone in the diagnosis of cervical cancer but the prognostic value is controversial. Methods: Women under active follow-up for histologically confirmed primary invasive cervical cancer were selected from the United States Surveillance, Epidemiology, and End Results (SEER) 9-registries public use data 1973-2002. Only histologies with at least 100 cases were retained. Registry area, age, marital status, race, year of diagnosis, tumor histology, grade, stage, tumor size, number of positive nodes, number of examined nodes, odds of nodal involvement, extent of surgery, and radiotherapy were evaluated in Cox models by stepwise selection using the Akaike Information Criteria. Results: There were 30,989 records evaluable. From 1973 to 2002, number of cases dropped from 1,100 new cases/year to 900/year, but adenocarcinomas and adenosquamous carcinoma increased from 100/year to 235/year. Median age was 48 years. Statistically significant variables for both overall and cause-specific mortality were: age, year of diagnosis, race, stage, histology, grade, hysterectomy, radiotherapy, tumor size and nodal ratio. The histological types were jointly significant, P <0.001. Cause-specific mortality hazard ratios by histological type relatively to non-microinvasive squamous cell carcinoma were: microinvasive squamous cell carcinoma 0.28 (95{\%} confidence interval: 0.20-0.39), carcinoma not otherwise specified 0.91 (0.79-1.04), non-mucinous adenocarcinoma 1.06 (0.98-1.15), adenosquamous carcinoma 1.35 (1.20-1.51), mucinous adenocarcinoma 1.52 (1.23-1.88), small cell carcinoma 1.94 (1.58-2.39). Conclusion: Small cell carcinoma and adenocarcinomas were associated with poorer survival. The incidental observation of increasing numbers of adenocarcinomas despite a general decline suggests the inefficiency of conventional screening for these tumors. Increased incidence of adenocarcinomas, their adverse prognosis, and the young age at diagnosis indicate the need to identify women who are at risk.",
author = "Vincent Vinh-Hung and Claire Bourgain and Georges Vlastos and G. Cserni and {De Ridder}, Mark and Guy Storme and Vlastos, {Anne Th{\'e}r{\`e}se}",
year = "2007",
month = "8",
day = "23",
doi = "10.1186/1471-2407-7-164",
language = "English",
volume = "7",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Prognostic value of histopathology and trends in cervical cancer

T2 - A SEER population study

AU - Vinh-Hung, Vincent

AU - Bourgain, Claire

AU - Vlastos, Georges

AU - Cserni, G.

AU - De Ridder, Mark

AU - Storme, Guy

AU - Vlastos, Anne Thérèse

PY - 2007/8/23

Y1 - 2007/8/23

N2 - Background: Histopathology is a cornerstone in the diagnosis of cervical cancer but the prognostic value is controversial. Methods: Women under active follow-up for histologically confirmed primary invasive cervical cancer were selected from the United States Surveillance, Epidemiology, and End Results (SEER) 9-registries public use data 1973-2002. Only histologies with at least 100 cases were retained. Registry area, age, marital status, race, year of diagnosis, tumor histology, grade, stage, tumor size, number of positive nodes, number of examined nodes, odds of nodal involvement, extent of surgery, and radiotherapy were evaluated in Cox models by stepwise selection using the Akaike Information Criteria. Results: There were 30,989 records evaluable. From 1973 to 2002, number of cases dropped from 1,100 new cases/year to 900/year, but adenocarcinomas and adenosquamous carcinoma increased from 100/year to 235/year. Median age was 48 years. Statistically significant variables for both overall and cause-specific mortality were: age, year of diagnosis, race, stage, histology, grade, hysterectomy, radiotherapy, tumor size and nodal ratio. The histological types were jointly significant, P <0.001. Cause-specific mortality hazard ratios by histological type relatively to non-microinvasive squamous cell carcinoma were: microinvasive squamous cell carcinoma 0.28 (95% confidence interval: 0.20-0.39), carcinoma not otherwise specified 0.91 (0.79-1.04), non-mucinous adenocarcinoma 1.06 (0.98-1.15), adenosquamous carcinoma 1.35 (1.20-1.51), mucinous adenocarcinoma 1.52 (1.23-1.88), small cell carcinoma 1.94 (1.58-2.39). Conclusion: Small cell carcinoma and adenocarcinomas were associated with poorer survival. The incidental observation of increasing numbers of adenocarcinomas despite a general decline suggests the inefficiency of conventional screening for these tumors. Increased incidence of adenocarcinomas, their adverse prognosis, and the young age at diagnosis indicate the need to identify women who are at risk.

AB - Background: Histopathology is a cornerstone in the diagnosis of cervical cancer but the prognostic value is controversial. Methods: Women under active follow-up for histologically confirmed primary invasive cervical cancer were selected from the United States Surveillance, Epidemiology, and End Results (SEER) 9-registries public use data 1973-2002. Only histologies with at least 100 cases were retained. Registry area, age, marital status, race, year of diagnosis, tumor histology, grade, stage, tumor size, number of positive nodes, number of examined nodes, odds of nodal involvement, extent of surgery, and radiotherapy were evaluated in Cox models by stepwise selection using the Akaike Information Criteria. Results: There were 30,989 records evaluable. From 1973 to 2002, number of cases dropped from 1,100 new cases/year to 900/year, but adenocarcinomas and adenosquamous carcinoma increased from 100/year to 235/year. Median age was 48 years. Statistically significant variables for both overall and cause-specific mortality were: age, year of diagnosis, race, stage, histology, grade, hysterectomy, radiotherapy, tumor size and nodal ratio. The histological types were jointly significant, P <0.001. Cause-specific mortality hazard ratios by histological type relatively to non-microinvasive squamous cell carcinoma were: microinvasive squamous cell carcinoma 0.28 (95% confidence interval: 0.20-0.39), carcinoma not otherwise specified 0.91 (0.79-1.04), non-mucinous adenocarcinoma 1.06 (0.98-1.15), adenosquamous carcinoma 1.35 (1.20-1.51), mucinous adenocarcinoma 1.52 (1.23-1.88), small cell carcinoma 1.94 (1.58-2.39). Conclusion: Small cell carcinoma and adenocarcinomas were associated with poorer survival. The incidental observation of increasing numbers of adenocarcinomas despite a general decline suggests the inefficiency of conventional screening for these tumors. Increased incidence of adenocarcinomas, their adverse prognosis, and the young age at diagnosis indicate the need to identify women who are at risk.

UR - http://www.scopus.com/inward/record.url?scp=34848875722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848875722&partnerID=8YFLogxK

U2 - 10.1186/1471-2407-7-164

DO - 10.1186/1471-2407-7-164

M3 - Article

C2 - 17718897

AN - SCOPUS:34848875722

VL - 7

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

M1 - 164

ER -